We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

171 hedge funds and large institutions have $877M invested in Ariad Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 48 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 48

10% more capital invested

Capital invested by funds: $801M → $877M (+$76.3M)

3% more funds holding

Funds holding: 166 → 171 (+5)

7% more call options, than puts

Call options by funds: $53.1M | Put options by funds: $49.5M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
171
Holders Change
+5
Holders Change %
+3.01%
% of All Funds
4.94%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
36
Increased
56
Reduced
48
Closed
30
Calls
$53.1M
Puts
$49.5M
Net Calls
+$3.61M
Net Calls Change
+$16.2M

Top Buyers

Rank Fund Capital Flow
1
SPC
Slate Path Capital
New York
+$51.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$24.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.5M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.73M
5
ARTA
A.R.T. Advisors
New York
+$4.43M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$28.7M
2
CCM
Camber Capital Management
Massachusetts
-$17.5M
3
Franklin Resources
Franklin Resources
California
-$16.7M
4
Barclays
Barclays
United Kingdom
-$14M
5
PC
PointState Capital
New York
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nomura Holdings
26
Nomura Holdings
Japan
$5.39M -$3.16M -406,184 -38%
GPCM
27
Granite Point Capital Management
Massachusetts
$5.22M -$4.3M -552,000 -46%
IIM
28
Ironwood Investment Management
Massachusetts
$4.98M +$105K +13,438 +2%
PC
29
PointState Capital
New York
$4.84M -$12.5M -1,600,000 -73%
Morgan Stanley
30
Morgan Stanley
New York
$4.71M +$1.85M +237,559 +69%
Axa
31
Axa
France
$4.67M -$3.01M -386,940 -40%
ARTA
32
A.R.T. Advisors
New York
$4.58M +$4.43M +568,559 New
BNP Paribas Asset Management
33
BNP Paribas Asset Management
France
$4.21M -$308K -39,520 -7%
RA
34
Royce & Associates
New York
$4.16M -$1.32M -170,000 -25%
U
35
UBS
Switzerland
$4.08M +$2.1M +269,088 +114%
SFM
36
Soros Fund Management
New York
$4.03M -$11.3M -1,450,000 -74%
PPA
37
Parametric Portfolio Associates
Washington
$3.99M +$116K +14,896 +3%
Goldman Sachs
38
Goldman Sachs
New York
$3.24M -$4.03M -517,781 -56%
SC
39
Selz Capital
New York
$3.22M – – –
CS
40
Credit Suisse
Switzerland
$3.04M -$154K -19,831 -5%
Group One Trading
41
Group One Trading
Illinois
$3.03M -$4.7M -603,173 -62%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$2.9M +$2.6M +334,137 +1,312%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$2.82M – – –
Allianz Asset Management
44
Allianz Asset Management
Germany
$2.81M -$1.63M -209,000 -37%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$2.71M +$10.9K +1,400 +0.4%
CA
46
Commerzbank Aktiengesellschaft
Germany
$2.64M +$1.61M +206,412 +170%
Charles Schwab
47
Charles Schwab
California
$2.46M -$175K -22,508 -7%
CNB
48
City National Bank
California
$2.43M +$835K +107,235 +55%
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$2.39M -$170K -21,849 -7%
ECP
50
Elk Creek Partners
Colorado
$2.35M +$770K +98,921 +52%
1
2
3 4 5

ARIA Hedge Fund Activity: Q1 2014 in Review

171 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2014, worth a combined $877M — up 9.5% from $801M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ARIA positions and 30 closed out — a net gain of 6 holders — while 56 added to existing stakes and 48 trimmed.

The largest buyer was Slate Path Capital, opening a new position worth an estimated $51.6M. The largest seller was Fidelity Investments, cutting an estimated $28.7M.

  • 171 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2014, up from 166 in Q4 2013.
  • Funds reported $877M of Ariad Pharmaceuticals Inc stock for Q1 2014, up 9.5% quarter-over-quarter.
  • 36 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2014 and 30 closed out, a net change of +6 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2014 was Slate Path Capital, an estimated $51.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2014 was Fidelity Investments, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2014.